FIA
HAE icon

FNY Investment Advisers’s Haemonetics HAE Stock Holding History

FNY Investment Advisers’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-4,800
Closed -$233K – 1123
2025
Q3 		$233K Buy
+4,800
New +$297K 0.07% 250
2022
Q3 		– Sell
-1,156
Closed -$75K – 722
2022
Q2 		$75K Buy
+1,156
New +$68.4K 0.06% 190
2019
Q1 		– Sell
-104
Closed -$10K – 789
2018
Q4 		$10K Buy
+104
New +$10.9K ﹤0.01% 426

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $44.4B AUM 57.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

FNY Investment Advisers's HAE Position: Q4 2025 in Review

FNY Investment Advisers sold out of Haemonetics (HAE) in Q4 2025, closing a stake of 4,800 shares — an estimated $233K sold.

FNY Investment Advisers first reported a position in HAE in Q4 2018 and held it in 3 quarters. The position peaked at $233K in Q3 2025. 329 funds tracked by Wall St. Rank hold HAE as of Q4 2025.

  • FNY Investment Advisers reported no remaining Haemonetics position as of Q4 2025 after selling out during the quarter.
  • FNY Investment Advisers sold 4,800 Haemonetics shares in Q4 2025, an estimated $233K.
  • FNY Investment Advisers first reported a position in Haemonetics in Q4 2018 and held it in 3 quarters.
  • FNY Investment Advisers's Haemonetics position peaked at $233K in Q3 2025.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q4 2025.

Based on FNY Investment Advisers's 13F filing for Q4 2025, filed 16 Jan 2026.